Chemical Compound

N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-{[(3S)-1-azabicyclo[2.2.2]octan-3-ylsulfanyl]methyl}-3-{[4-(dimethylamino)phenyl]methyl}-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.0,6,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide

CAS Registry Number 120138-50-3
返回搜索 申请报价
N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-{[(3S)-1-azabicyclo[2.2.2]octan-3-ylsulfanyl]methyl}-3-{[4-(dimethylamino)phenyl]methyl}-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.0,6,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide 结构式
Primary record

N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-{[(3S)-1-azabicyclo[2.2.2]octan-3-ylsulfanyl]methyl}-3-{[4-(dimethylamino)phenyl]methyl}-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.0,6,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide

库存
2,635 克
纯度
99.6 %
CAS
120138-50-3

化合物标识与属性

CAS
120138-50-3
PubChem CID
5388937
SMILES
CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
Canonical SMILES
CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O

名称与同义词

  • Quinupristin
  • Quinupristina
  • Quinupristine
  • Quinupristinum
  • Synercid
  • Quinupristin?
  • quinupristin mesilate
  • quinupristin mesylate
  • Antibiotic RP 57669
  • QuinupristinDiscontinued
  • Quinupristine [INN-French]
  • Quinupristinum [INN-Latin]
  • Quinupristina [INN-Spanish]
  • Quinupristin [USAN:INN]
  • RefChem:178373
  • 23OW28RS7P
  • Antibiotic RP-57669
  • QUINUPRISTIN [MI]
  • UNII-23OW28RS7P
  • 120138-50-3
  • QUINUPRISTIN [INN]
  • QUINUPRISTIN [JAN]
  • RP 57669
  • QUINUPRISTIN [USAN]
  • RP-57669
  • Quinupristin [USAN:INN:BAN]
  • QUINUPRISTIN [VANDF]
  • SCHEMBL40782
  • HSDB 8067
  • QUINUPRISTIN [WHO-DD]
  • C53H67N9O10S
  • CHEMBL1200649
  • GTPL10798
  • DTXSID00873377
  • 2-anilino-nicotinic acid hydrazide
  • DTXCID601508623
  • QUINUPRISTIN [ORANGE BOOK]
  • RP 68888
  • HY-A0162
  • BBF-04415
  • EBC-27514
  • EX-A14978
  • SYNERCID COMPONENT QUINUPRISTIN
  • C53-H67-N9-O10-S
  • CID5388937
  • DB01369
  • RP57669
  • Synercid (dalfopristin + quinupristin)
  • DA-57314
  • J492.986A
  • LS-172437
  • CS-0017494
  • 5delta-(3-quinuclidinyl)thiomethylpristinamycin IA
  • EN300-28266000
  • Q7272542
  • 5delta-[(3S)-3-quinuclidinyl]thiomethylpristinamycin IA
  • N-((6R,9S,10R,13S,15aS,18R,22S,24aS)-22-(p-(Dimethylamino)benzyl)-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-18-(((3S)-3-quinuclidinylthio)methyl)-12H-pyrido(2,1-f)pyrrolo(2,1-l)(1,4,7,10,13,16)oxapentaazacyclononadecin-9-yl)-3-hydroxypicolinamide
  • N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
  • Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)-, (S)-
  • 4-[4-(Dimethylamino)-N-methyl-L-phenylalanine]-5-[(2S,5R)-5-[[[(3S)-1-azabicyclo[2.2.2]oct-3-yl]thio]methyl]-4-oxo-2-piperidinecarboxylic acid]virginiamycin S1
  • B6
  • N-((3S,6S,12R,15S,16R,19S,22S,25R)-25-(((3S)-1-azabicyclo(2.2.2)octan-3-yl)sulfanylmethyl)-3-((4-(dimethylamino)phenyl)methyl)-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo(20.4.0.06,10)hexacosan-15-yl)-3-hydroxypyridine-2-carboxamide
  • N-((6R,9S,10R,13S,15aS,18R,22S,24aS)-22-(4-(dimethylamino)benzyl)-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-18-((((S)-quinuclidin-3-yl)thio)methyl)docosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1]oxa[4,7,10,13,16]pentaazacyclononadecin-9-yl)-3-hydroxypicolinamide
  • N-[(3-Hydroxy-2-pyridinyl)carbonyl]cyclo(L-Thr*-D-Abu-L-Pro-N-methyl-4-(dimethylamino)-L-Phe-5alpha-[[(quinuclidin-3beta-yl)thio]methyl]-4-oxo-L-Hpr-L-phenyl Gly-)
  • N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-{[(3S)-1-azabicyclo[2.2.2]octan-3-ylsulfanyl]methyl}-3-{[4-(dimethylamino)phenyl]methyl}-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.0,6,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
  • N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-{[(3S)-1-azabicyclo[2.2.2]octan-3-ylsulfanyl]methyl}-3-{[4-(dimethylamino)phenyl]methyl}-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
  • Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic Acid)-,(S)-
  • VIRGINIAMYCIN S1, 4-(4-(DIMETHYLAMINO)-N-METHYL-L-PHENYLALANINE)-5-(5-(1-AZABICYCLO(2.2.2)OCT-3-YLTHIO)METHYL)-4-OXO-L-2-PIPERIDINECARBOXYLIC ACID)-, (S)-